AAAAAA
Results: 1-25/43
Authors:
FISCHER JS
JACOBS LD
COOKFAIR DL
RUDICK RA
Citation: Js. Fischer et al., HETEROGENEITY OF COGNITIVE DYSFUNCTION IN MULTIPLE-SCLEROSIS, Clinical neuropsychologist, 12(2), 1998, pp. 286-286
Authors:
PELFREY CM
WEINSTOCKGUTTMAN B
RUDICK RA
LEHMANN PV
Citation: Cm. Pelfrey et al., ELISPOT ANALYSIS OF PLP RESPONSES IN MS, The FASEB journal, 12(5), 1998, pp. 6361-6361
Authors:
SIMON JH
JACOBS LD
CAMPION M
WENDE K
SIMONIAN N
COOKFAIR DL
RUDICK RA
HERNDON RM
RICHERT JR
SALAZAR AM
ALAM JJ
FISCHER JS
GOODKIN DE
GRANGER CV
LAJAUNIE M
MARTENSDAVIDSON AL
MEYER MJ
SHEEDER J
CHOI K
SCHERZINGER AL
BARTOSZAK DM
BOURDETTE DN
BRAIMAN J
BROWNSCHEIDLE CM
COATS ME
COHAN SL
DOUGHERTY DS
KINKEL RP
MASS MK
MUNSCHAUER FE
PRIORE RL
PULLICINO PM
SCHEROKMAN BJ
WEINSTOCKGUTTMAN B
WHITHAM RH
Citation: Jh. Simon et al., MAGNETIC-RESONANCE STUDIES OF INTRAMUSCULAR INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 43(1), 1998, pp. 79-87
Authors:
RUDICK RA
Citation: Ra. Rudick, A 29-YEAR-OLD MAN WITH MULTIPLE-SCLEROSIS, JAMA, the journal of the American Medical Association, 280(16), 1998, pp. 1432-1439
Authors:
RUDICK RA
SIMONIAN NA
ALAM JA
CAMPION M
SCARAMUCCI JO
JONES W
COATS ME
GOODKIN DE
WEINSTOCKGUTTMAN B
HERNDON RM
MASS MK
RICHERT JR
SALAZAR AM
MUNSCHAUER FE
COOKFAIR DL
SIMON JH
JACOBS LD
Citation: Ra. Rudick et al., INCIDENCE AND SIGNIFICANCE OF NEUTRALIZING ANTIBODIES TO INTERFERON BETA-1A IN MULTIPLE-SCLEROSIS, Neurology, 50(5), 1998, pp. 1266-1272
Authors:
RUDICK RA
RANSOHOFF RM
LEE JC
PEPPLER R
YU M
MATHISEN PM
TUOHY VK
Citation: Ra. Rudick et al., IN-VIVO EFFECTS OF INTERFERON BETA-1A ON IMMUNOSUPPRESSIVE CYTOKINES IN MULTIPLE-SCLEROSIS, Neurology, 50(5), 1998, pp. 1294-1300
Authors:
MILLER DM
FISCHER JS
CUTTER G
ANDREWS H
LAROCCA NG
PATY D
RITVO P
RUDICK RA
Citation: Dm. Miller et al., VALIDATION OF A NEW MULTIPLE-SCLEROSIS CLINICAL OUTCOME MEASURE USINGPATIENT REPORTED QUALITY-OF-LIFE, Neurology, 50(4), 1998, pp. 5115-5115
Authors:
SIMON JH
JACOBS LD
CAMPION M
RUDICK RA
Citation: Jh. Simon et al., A LONGITUDINAL-STUDY OF BRAIN ATROPHY IN RELAPSING MS, Neurology, 50(4), 1998, pp. 17006-17006
Authors:
WEINSTOCKGUTTMAN B
RUDICK RA
Citation: B. Weinstockguttman et Ra. Rudick, PRESCRIBING RECOMMENDATIONS FOR INTERFERON-BETA IN MULTIPLE-SCLEROSIS, CNS DRUGS, 8(2), 1997, pp. 102-112
Authors:
HERNDON RM
COATS M
GOODKIN D
MASS M
RICHERT J
RUDICK RA
WEINSTOCKGUTTMAN B
SIMONIAN NA
CAMPION M
SCARAMOCCI J
ALAM JJ
JACOBS LD
Citation: Rm. Herndon et al., ONGOING EFFICACY AND SAFETY ANALYSIS OF INTERFERON-BETA-1A (AVONEX) IN PATIENTS WITH MULTIPLE-SCLEROSIS, Annals of neurology, 42(6), 1997, pp. 6-6
Authors:
AIKENS JE
FISCHER JS
NAMEY M
RUDICK RA
Citation: Je. Aikens et al., A REPLICATED PROSPECTIVE INVESTIGATION OF LIFE STRESS, COPING, AND DEPRESSIVE SYMPTOMS IN MULTIPLE-SCLEROSIS, Journal of behavioral medicine, 20(5), 1997, pp. 433-445
Authors:
RUDICK RA
COHEN JA
WEINSTOCKGUTTMAN B
KINKEL RP
RANSOHOFF RM
Citation: Ra. Rudick et al., MANAGEMENT OF MULTIPLE-SCLEROSIS, The New England journal of medicine, 337(22), 1997, pp. 1604-1611
Authors:
RUDICK RA
GOODKIN DE
JACOBS LD
COOKFAIR DL
HERNDON RM
RICHERT JR
SALAZAR AM
FISCHER JS
GRANGER CV
SIMON JH
ALAM JJ
SIMONIAN NA
CAMPION MK
BARTOSZAK DM
BOURDETTE DN
BRAIMAN J
BROWNSCHEIDLE CM
COATS ME
COHAN SL
DOUGHERTY DS
KINKEL RP
MASS MK
MUNSCHAUER FE
PRIORE RL
PULLICINO PM
SCHEROKMAN BJ
WEISTOCKGUTTMAN B
WHITHAM RH
Citation: Ra. Rudick et al., IMPACT OF INTERFERON BETA-1A ON NEUROLOGIC DISABILITY IN RELAPSING MULTIPLE-SCLEROSIS, Neurology, 49(2), 1997, pp. 358-363
Authors:
RUDICK RA
JONES W
ALAM J
SIMONIAN N
CAMPION M
JACOBS L
HERNDON R
RICHERT J
SALAZAR A
COOKFAIR D
SIMON J
COATS M
GOODKIN D
MASS M
Citation: Ra. Rudick et al., SIGNIFICANCE OF SERUM NEUTRALIZING ANTIBODIES TO AVONEX' (IFN-BETA-1A) IN MULTIPLE-SCLEROSIS, Neurology, 48(3), 1997, pp. 5003-5003
Authors:
WEINSTOCKGUTTMAN B
KINKEL RP
COHEN JA
RANSOHOFF RR
RUDICK RA
Citation: B. Weinstockguttman et al., TREATMENT OF TRANSITIONAL MS WITH CYCLOPHOSPHAMIDE AND METHYLPREDNISOLONE (CTX MP) FOLLOWED BY INTERFERON-BETA/, Neurology, 48(3), 1997, pp. 45006-45006
Authors:
KINKEL RP
RUDICK RA
RANSOHOFF RM
Citation: Rp. Kinkel et al., RAPID NEUROLOGICAL DETERIORATION IN A PATIENT WITH MULTIPLE-SCLEROSISTREATED WITH SYSTEMIC INTERLEUKIN-2 AND INTERFERON-ALPHA-2B FOR METASTATIC RENAL-CELL CARCINOMA, Journal of Neurology, Neurosurgery and Psychiatry, 62(1), 1997, pp. 100-100
Authors:
MOHR DC
GOODKIN DE
LIKOSKY W
GATTO N
BAUMANN KA
RUDICK RA
Citation: Dc. Mohr et al., TREATMENT OF DEPRESSION IMPROVES ADHERENCE TO INTERFERON BETA-1B THERAPY FOR MULTIPLE-SCLEROSIS, Archives of neurology, 54(5), 1997, pp. 531-533
Authors:
WINEMAN NM
SCHWETZ KM
GOODKIN DE
RUDICK RA
Citation: Nm. Wineman et al., RELATIONSHIPS AMONG ILLNESS UNCERTAINTY, STRESS, COPING, AND EMOTIONAL WELL-BEING AT ENTRY INTO A CLINICAL DRUG TRIAL, Applied nursing research, 9(2), 1996, pp. 53-60
Authors:
RUDICK RA
RANSOHOFF RM
PEPPLER R
MEDENDORP SV
LEHMANN P
ALAM J
Citation: Ra. Rudick et al., INTERFERON-BETA INDUCES INTERLEUKIN-10 EXPRESSION - RELEVANCE TO MULTIPLE-SCLEROSIS, Annals of neurology, 40(4), 1996, pp. 618-627
Authors:
RUDICK RA
COOKFAIR RD
RANSOHOFF R
JACOBS L
HERNDON R
RICHERT J
SALAZAR A
FISCHER J
GRANGER C
SIMON J
GOODKIN D
Citation: Ra. Rudick et al., CEREBROSPINAL-FLUID ABNORMALITIES IN A PHASE-III TRIAL INTERFERON BETA-1A (AVONEX) FOR RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 104-104
Authors:
RUDICK RA
RANSOHOFF R
MEDENDORP S
BOYLE S
PEPPLER R
JACOBS L
COCKFAIR D
HERNDON R
RICHERT J
SALAZAR A
FISCHER J
GRANGER C
SIMON J
GOODKIN D
WENDE K
Citation: Ra. Rudick et al., INTERFERON BETA-1A (AVONEX) INCREASES CEREBROSPINAL-FLUID INTERLEUKIN-10 IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 244-244
Authors:
JACOBS LD
COOKFAIR DL
RUDICK RA
HERNDON RM
RICHERT JR
SALAZAR AM
FISCHER JS
GOODKIN DE
GRANGER CV
SIMON JH
ALAM JJ
BARTOSZAK DM
BOURDETTE DN
BRAIMAN J
BROWNSCHEIDLE CM
COATS ME
COHAN SL
DOUGHERTY DS
KINKEL RP
MASS MK
MUNSCHAUER FE
PRIORE RL
PULLICINO PM
SCHEROKMAN BJ
WEINSTOCKGUTTMAN B
WHITMAN RH
BAIRD WC
FILLMORE M
BONA LM
COLONRUIZ ME
NADINE BS
DONOVAN A
BENNETT S
KIEFFER YM
UMHAUER MA
MILLER CE
KILIC AK
SARGENT EL
SCHACHTER M
SHUCARD DW
WEIDER V
CATALANO BA
CERVI JM
CZEKAY C
FARRELL JL
FILIPPINI JS
MATYAS RC
MICHIENZI KE
ITO M
OMALLEY JA
ZIELEZNY MA
BRUN JM
DAVIDSON AL
GREEN LA
OREILLY KM
SHELTON JA
WENDE KE
BARILLA DY
BOYLE SL
PERKINS KK
PERRYMAN JE
STIEBELING BG
KONECSNI JF
ROSS JS
CHOI KS
GUSTAFSON CJ
QUANDT BJ
SCHERZINGER AL
GRIFFITH DA
HARRIS JM
LEZAK MD
MIMICA I
SAUNDERS JA
COIT WE
FORCE CR
GILMORE FJ
HARRIS LB
JONES MM
KAUFFMAN JA
MARBERGER KE
MCBRIDE JW
MILLER LL
WRIGHT GK
BROOKS JA
BROWN HR
GRAVES ME
SCHMIDT JA
MOTHENA JW
GRAFMAN JH
KENWORTHY MK
MORTON MM
BROWN DM
BROWN DC
LEVY LM
BORDEN EC
RANSOHOFF RM
VILCEK JT
MCCARTHYKIRBY K
CAMPION M
Citation: Ld. Jacobs et al., INTRAMUSCULAR INTERFERON BETA-1-ALPHA FOR DISEASE PROGRESSION IN RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 39(3), 1996, pp. 285-294
Authors:
GOODKIN DE
RUDICK RA
MEDENDORP SVB
DAUGHTRY MM
VANDYKE C
Citation: De. Goodkin et al., LOW-DOSE ORAL METHOTREXATE IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS - ANALYSES OF SERIAL MRIS, Neurology, 47(5), 1996, pp. 1153-1157
Authors:
GOODKIN DE
HERNDON RM
JACOBS LD
COOKFAIR DL
RUDICK RA
RICHERT JR
SALAZAR AM
FISCHER JS
GRANGER CV
SIMON JH
PRIORE R
Citation: De. Goodkin et al., INTRAMUSCULAR INTERFERON-BETA-1A IN RELAPSING MULTIPLE-SCLEROSIS - ANALYSES OF QUANTITATIVE UPPER EXTREMITY TESTING, Neurology, 46(2), 1996, pp. 1074-1074
Authors:
MEDENDORP S
GOODKIN DE
RUDICK RA
VANDYKE C
Citation: S. Medendorp et al., LOW-DOSE ORAL METHOTREXATE IN CPMS - FINAL ANALYSES OF MRI SCANS, Neurology, 46(2), 1996, pp. 3087-3087